Synapse Open Synapse
Biology

Engineered mechanosensitive MSCs enable synthetic radiotheranostic targeting across tumor types

Cell Stem Cell · · 1 min read

Many cancers lack suitable molecular targets for radiotheranostics. Liu and colleagues engineer mechanosensitive MSCs that convert tumor stiffness into synthetic expression of clinically actionable targets, thereby guiding radiopharmaceuticals for PET imaging and targeted radionuclide therapy.

Latest from Cell Stem Cell